Industries > Pharma > Global Allergic Rhinitis Drugs Market 2018-2028

Global Allergic Rhinitis Drugs Market 2018-2028

Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines

PUBLISHED: 24 August 2018
PAGES: 256
PRODUCT CODE: PHA0328

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0328 Categories: , , Tag:

The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.3% in the first half of the forecast period. The market is estimated at $12.2bn in 2017 and $14.3bn in 2022.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 256-page report you will receive 97 tables and 100 figures– all unavailable elsewhere.

The 256-page report provides clear detailed insight into the global allergic rhinitis drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Allergic Rhinitis Drugs Market forecasts from 2018-2028

• Along with revenue prediction for the overall world market for allergic rhinitis drugs, our investigation shows forecasts to 2028 for the following submarkets:
• Intranasal Antihistamines
• Intranasal Corticosteroids
• Oral Antihistamines
• Immunotherapy and Vaccines

Global Allergic Rhinitis Drugs Market 2018-2028

• How will leading allergic rhinitis drugs perform to 2028 at world level? Our study forecasts individual revenues of these 27 products:
• Patanase
• Astepro
• Astelin
• Dymista
• Nasonex
• Avamys
• Veramyst
• Flixonase
• Rhinocort
• Omnaris
• Nasacort
• Beconase
• Qnasl
• Zetonna
• Allegra
• Zyrtec
• Claritin
• Xyzal
• Allelock
• Clarinex
• Ebastel
• Talion
• Staloral
• Alutard SQ
• Grazax
• Ragwitek
• Generic Azelastine

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• US
• EU5 – Germany, UK, France, Italy and Spain
• China
• Japan
• India
• Russia
• Brazil
• Rest of the World

Each national market is further segmented by submarket.

• Our work provides analysis and sales forecast of the leading companies in the allergic rhinitis drugs market:
• GlaxoSmithKline (GSK)
• Merck & Co
• Sanofi
• Johnson & Johnson
• ALK-Abello
• UCB
• Kyowo Hako Kirin
• Stallergenes Greer

• This report discusses the trends and development in the allergic rhinitis pipeline

• Our study discusses strengths, weaknesses, opportunities and threats as well as porter’s five forces analysis of the global allergic rhinitis drugs market

Visiongain’s study is intended for anyone requiring commercial analyses for the global allergic rhinitis drugs market. You find data, trends and predictions.

Buy our report today Allergic Rhinitis Drugs Market Forecast : Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Allergic Rhinitis Drugs Market 2018-2028

    Download sample pages

    Complete the form below to download your free sample pages for Global Allergic Rhinitis Drugs Market 2018-2028

      Latest Pharma news

      Visiongain Publishes Human Microbiome Market Report 2023-2033

      The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.

      30 January 2023

      READ

      Visiongain Publishes Allergic Rhinitis Drugs Market Report 2023-2033

      The global Allergic Rhinitis Drugs market was valued at US$12,025.2 million in 2022 and is projected to grow at a CAGR of 3.78% during the forecast period 2023-2033.

      30 January 2023

      READ

      Visiongain Publishes Women’s Health Market Report 2023-2033

      The global Women’s Health market was valued at US$36,567.3 million in 2022 and is projected to grow at a CAGR of 4.1% during the forecast period 2023-2033.

      30 January 2023

      READ

      Visiongain Publishes Biodefence Market Report 2023-2033

      The global Biodefence market was valued at US$14,675.0 million in 2022 and is projected to grow at a CAGR of 7.78% during the forecast period 2023-2033.

      13 January 2023

      READ